Nom du produit:3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine

IUPAC Name:3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine

CAS:151266-23-8
Formule moléculaire:C5H4IN5
Pureté:98%
Numéro de catalogue:CM103555
Poids moléculaire:261.03

Unité d'emballage Stock disponible Prix($) Quantité
CM103555-100g in stock ƏşƏ
CM103555-500g in stock œŭƩ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:151266-23-8
Formule moléculaire:C5H4IN5
Point de fusion:-
Code SMILES:NC1=NC=NC2=C1C(I)=NN2
Densité:
Numéro de catalogue:CM103555
Poids moléculaire:261.03
Point d'ébullition:
N° Mdl:MFCD03787931
Stockage:Keep in a tight container and store at 2°C~8°C,protect from light

Category Infos

Pyrazolopyrimidines
Pyrazolopyrimidine scaffolds are one of the most important heterocyclic compounds in drug discovery. This scaffold has various biological activities, among which anticancer is an important one.

Column Infos

Rilzabrutinib
Positive results from the Phase 2 study RILECSU showed that rilzabrutinib significantly improved itch, hives and urticaria in adults with moderate-to-severe chronic spontaneous urticaria (CSU), whose symptoms are not adequately controlled by H1 antihistamines. These results were released at the 2024 American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting and form the basis for the Phase 3 program which is on track to start in 2024. Rilzabrutinib is an oral, reversible, covalent BTK inhibitor that has the potential to be a first- or best-in-class treatment of a number of immune-mediated diseases.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products